Bladder Cancer is A Serious Side Effect for Many Taking
Diabetes Drug Actos, Drug Injury Lawyers Blog, November 13, 2012 Continue reading
European Medicines Agency will decide whether
the diabetes drug Actos should remain on the market
Bladder Cancer is A Serious Side Effect for Many Taking
Diabetes Drug Actos, Drug Injury Lawyers Blog, November 13, 2012 Whether generic or brand, medications that are dangerous, defective in design, improperly marketed, or come with poor instructions and inadequate warnings can cause serious injuries and even death to consumers.
As you may know,
the diabetes drug Actos, ActoPlus Met, ActoPlus Met XR, or Duetact have been linked to bladder cancer and other serious side effects.
Not exact matches
Two days later, the FDA, which had already been assessing the health risks of Avandia, imposed its toughest warning label, the «black box,» on the
drug, as well as on
Actos, another
drug used to treat
diabetes.
In their recent study, the UCSF team reports the discovery that a class of commonly prescribed Type - 2
diabetes drugs, called TZDs (thiazolidinediones, such as
Actos and Avandia), promoted the conversion of white fat cells into brown (in mice and culture dishes) by stabilizing the PRDM16 protein.
And while
Actos or its generic version both help to stabilize blood sugar, so do other
diabetes drugs, according to Dr. Jardini.
For instance, one of the newer
drugs to treat
diabetes is
Actos, which costs about $ 1,000 for a 90 - day treatment of the lowest starting dose (15 mg).
FDA approves first generic
Actos to treat type 2
diabetes, US Food and
Drug Administration, August 17, 2012
Meantime, more people are coming forward to file their
Actos lawsuits against
drug maker Takeda Pharmaceuticals, its subsidiaries, and Eli Lilly, which has been active in marketing the
diabetes drug in the US.
Our
drug injury attorneys work to protect the rights of patients harmed by dangerous
drugs like
Actos (pioglitazone), a Type 2
diabetes medication that poses serious health risks.
Actos» manufacturer, Takeda Pharmaceuticals, continues to dodge concerns about their
drug, citing the benefits of
Actos for patients who suffer from Type 2
diabetes as a reason why
Actos should remain available.
October 22, 2013 - A Georgia man taking
Actos diabetes medication for more than a year has filed a lawsuit against Takeda after developing bladder cancer, alleging the
drug caused the disease to develop.
More Blog Posts: Severe Skin Reactions Caused by Stevens - Johnson Syndrome are Linked to Different Prescription and OTC Medications,
Drug Injury Lawyers Blog, August 29, 2012 Despite
Actos Lawsuits, FDA Approves Type 2
Diabetes Drug's Generic Version,
Drug Injury Lawyers Blog, September 5, 2012 Boston Dangerous
Drug Lawsuits: YAZ, Ocella, and Yasmin Birth Control Pills Linked to Deep Vein Thrombosis, Pulmonary Embolism, Stroke, Heart Attack, and Myocardial Infarction Side Effects, Boston Injury Lawyers Blog, June 19, 2012 Continue reading
Symptoms of Bladder Cancer: • Blood in the urine • Straining or pain during urination • Urinating often • Incontinence • Fatigue • Bone tenderness • Pain • Weight loss FDA
Drug Safety Communication: Update to ongoing safety review of
Actos (pioglitazone) and increased risk of bladder cancer, FDA, June 15, 2011 The use of pioglitazone and the risk of bladder cancer in people with type 2
diabetes: nested case - control study, British Medical Journal, May 31, 2012
They also found that
Actos users with type II
diabetes that were taking the
drug for the first time had an 83 % greater risk of developing bladder cancer than other patients.
Actos Lawsuits Allow
Diabetes Patients to Pursue Dangerous
Drug Compensation from Takeda Pharmaceuticals America, Inc.,
Drug Injury Lawyers Blog, August 1, 2012
Although
Actos has been available to
diabetes users in the US for a number of years, it was just last year that the Food and
Drug Administration put out a Drug Safety Communication giving notification that the medication's label had been revised to include a warning that use of the drug for over a year dramatically increases the chances that the patient might develop bladder can
Drug Administration put out a
Drug Safety Communication giving notification that the medication's label had been revised to include a warning that use of the drug for over a year dramatically increases the chances that the patient might develop bladder can
Drug Safety Communication giving notification that the medication's label had been revised to include a warning that use of the
drug for over a year dramatically increases the chances that the patient might develop bladder can
drug for over a year dramatically increases the chances that the patient might develop bladder cancer.
More Blog Posts:
Actos Lawsuits Allow
Diabetes Patients to Pursue Dangerous
Drug Compensation from Takeda Pharmaceuticals America, Inc.,
Drug Injury Lawyers Blog, August 1, 2012
Already, numerous plaintiffs have filed
Actos injury lawsuits suing Takeda Pharmaceuticals because they believe the
diabetes drug caused their bladder cancer.